Guoxin Health (000503.SZ) announced semi-annual results, with a net loss of 102 million yuan to mother

According to Zhitong Finance App, Guoxin Health (000503.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved operating income of 102 million yuan, an increase of 6.30% over the previous year; net loss attributable to shareholders of listed companies of 102 million yuan; net loss of 102 million yuan attributable to shareholders of listed companies after deducting non-recurring profit and loss; and basic earnings per share - 0.1044 yuan.

During the reporting period, the company closely focused on the reform and development requirements of “healthy China” and “three medical collaboration”, with “three medical collaboration, innovation-driven, digital ecology” as the strategic lead, and “gathering, communication and use” of health care big data as the main line to accelerate data-driven innovation, use AI to empower the entire business upgrade, build a “three medicine” collaborative data governance application system, and actively implement the “9+6” strategic emerging industries, artificial intelligence+biomedicine, and future health industry layout.